Streetbeat News

Partnerships

META

NFLX

SPOT

The article discusses various entertainment news including the rivalry between Elon Musk and Mark Zuckerberg, with Musk threatening to sue Meta Platforms Inc for poaching Twitter employees. It also mentions the cancellation of Meghan Markle's podcast on Spotify after failing to reach an agreement on its launch. Netflix is also mentioned in relation to the timing of 'Titanic' being added to the platform.

Portfolio Pulse from Anthony Noto

July 08, 2023 | 12:35 pm

SFTBY

This week in AI saw predictions of AI surpassing human intellect by SoftBank Group's CEO, Masayoshi Son, and the integration of AI in wearable technology and the financial market. A smart home robot using ChatGPT from OpenAI was launched, and Goldman Sachs provided insight into the transformative potential of generative AI on U.S. equities. German Bionic is using AI in exoskeletons to assist workers, and Cronos Labs announced a partnership with Protocol Labs to drive the adoption of Web3 technologies.

Portfolio Pulse from Benzinga Newsbot

July 08, 2023 | 11:26 am

FLHLF

Filament Health (OTCQB:FLHLF) will supply psilocybin for two clinical studies funded by the Canadian Institutes of Health Research. The company will donate its pharma-grade botanical psilocybin drug candidate PEX010 for the trials. Filament has also entered into an exclusive global licensing agreement with NeoLumina Bioscience for PEX010 and its associated IP to be developed for eating disorders. Filament will receive milestone payments and future commercial royalties on a percentage of net sales.

Portfolio Pulse from Lara Goldstein

July 07, 2023 | 7:51 pm

BONEUSD

SHIBUSD

Shibarium, a project by Shiba Inu (CRYPTO: SHIB), is set to go live in August. The initiative aims to create a decentralized community leveraging blockchain technology. The project's structure is backed by Shib projects and the ShibArmy. The official launch will take place at the Blockchain Futurist Conference in August. The Shiba Inu ecosystem will introduce the Doggy DAO, which will govern the entire ecosystem, and the Shib Doggy DAO Foundation, which will manage the assets held by the DAO.

Portfolio Pulse from Murtuza Merchant

July 07, 2023 | 7:44 pm

LMT

SPY

VGK

The U.S. State Department has approved a possible foreign military sale to France of Hellfire missiles for $203M, according to Reuters.

Portfolio Pulse from Benzinga Newsdesk

July 07, 2023 | 7:09 pm

MCO

MSFT

Oppenheimer analyst Owen Lau reiterated an Outperform rating on Moody's Corporation (MCO), with a price target of $362. MCO's use of its proprietary GenAI tools across the organization is applauded. However, GenAI is seen as an enabler of workflow, not a substitute for credit analysts. MCO's partnership with Microsoft (MSFT) is also noted as a way to gain new customers. Lau expects MCO's 2Q23 revenues to increase by 9.8% Y/Y to $1.52 billion.

Portfolio Pulse from Nabaparna Bhattacharya

July 07, 2023 | 6:44 pm

MBGYY

TSLA

Mercedes Benz Group ADR (OTC:MBGYY) will provide its customers with the option of using and access more than 12,000 Tesla, Inc. (NASDAQ:TSLA) Superchargers in North America starting in 2024. Mercedes-Benz will also establish its own High-Power Charging Network with more than 400 charging hubs, including more than 2,500 high-power chargers in North America by the end of the decade. The first Mercedes-Benz charging hubs in North America will be opened by the end of 2023.

Portfolio Pulse from Shivani Kumaresan

July 07, 2023 | 4:36 pm

RIVN

TSLA

Rivian Automotive, Inc. (NASDAQ:RIVN) shares are surging after Wedbush raised its price target from $25 to $30. The stock has seen a significant increase over the last five sessions and the last 30 days, possibly due to strong Q2 deliveries and a charging partnership with Tesla, Inc. (NASDAQ:TSLA). RIVN's trading volume has also exceeded its 100-day average, and it has a high short interest with over 16% of available shares being sold short.

Portfolio Pulse from Erica Kollmann

July 07, 2023 | 3:58 pm

INM

InMed Pharmaceuticals Inc. (NASDAQ:INM) has published positive top-line data from its INM-755 Phase II study for the treatment of epidermolysis bullosa (EB), a rare genetic dermatological condition. The study supports further development of the cannabinol-based topical skin cream, INM-755. Following the data, InMed is exploring commercial partnerships for further development and distribution of the cream. The company is also open to early monetization opportunities through the sale or out-licensing of the program.

Portfolio Pulse from Javier Hasse

July 07, 2023 | 3:22 pm

FXI

SPY

US Treasury Secretary Janet Yellen has urged China's Premier Li Qiang to not let tensions over technology disrupt economic cooperation. Yellen defended US curbs on Chinese access to advanced processor chips and other technology, citing national security concerns. She also criticized China's treatment of US companies and its use of non-market tools like subsidies for state-owned enterprises. The Chinese finance ministry called Yellen's visit a 'concrete measure' toward improving relations but urged the US to take the first step. The US curbs on Chinese tech access could impact China's development in telecoms and AI.

Portfolio Pulse from Happy Mohamed

July 07, 2023 | 3:15 pm